Pfizer is recalling approximately 102,500 vials of Vancomycin Hydrochloride for Injection, USP (750 mg). This sterile powder, which is a generic antibiotic used to treat serious bacterial infections, was found to contain glass particulate matter inside the vials. If this medication is administered, the glass particles can cause serious internal health issues such as blood clots, organ damage, or inflammation. This recall specifically affects Hospira brand vials distributed across the United States and Puerto Rico.
The presence of glass particles in an injectable medication poses a critical risk because the shards can travel through the bloodstream. This can lead to local irritation, inflammation of the veins, or life-threatening complications like the blockage of blood vessels (embolism) which can cause strokes or damage to the lungs and other organs.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.